OMERS Administration Corp’s Regeneron Pharmaceuticals REGN Stock Holding History

OMERS Administration Corp’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.32M	Buy	8,179 +1,385	+20%	+$1.06M	0.04%	198
2025 Q4	$5.24M	Buy	6,794 +2,954	+77%	+$2.01M	0.04%	172
2025 Q3	$2.16M	Hold	3,840	–	–	0.02%	384
2025 Q2	$2.02M	Sell	3,840 -500	-12%	-$279K	0.02%	374
2025 Q1	$2.75M	Sell	4,340 -639	-13%	-$440K	0.02%	274
2024 Q4	$3.55M	Sell	4,979 -1,563	-24%	-$1.31M	0.03%	205
2024 Q3	$6.88M	Buy	6,542 +800	+14%	+$890K	0.06%	134
2024 Q2	$6.04M	Buy	+5,742	New	+$5.57M	0.06%	142
2020 Q1	–	Sell	-16,000	Closed	-$6.01M	–	346
2019 Q4	$6.01M	Sell	16,000 -15,400	-49%	-$5.18M	0.07%	165
2019 Q3	$8.71M	Buy	+31,400	New	+$9.29M	0.09%	130

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

OMERS Administration Corp's REGN Position: Q1 2026 in Review

OMERS Administration Corp increased its Regeneron Pharmaceuticals (REGN) stake by 20% in Q1 2026, buying an estimated $1.06M and bringing the position to 8,179 shares worth $6.32M. The position accounts for 0.04% of the portfolio, ranked #198.

OMERS Administration Corp first reported a position in REGN in Q3 2019 and has held it in 10 quarters since. The position peaked at $8.71M in Q3 2019. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

OMERS Administration Corp held 8,179 shares of Regeneron Pharmaceuticals worth $6.32M as of Q1 2026.
OMERS Administration Corp bought 1,385 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.06M.
Regeneron Pharmaceuticals made up 0.04% of OMERS Administration Corp's portfolio in Q1 2026, its #198 holding.
OMERS Administration Corp first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 10 quarters since.
OMERS Administration Corp's Regeneron Pharmaceuticals position peaked at $8.71M in Q3 2019.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.